Skip to main content

All Access Subscription

Get unlimited access to our full publication and article library.

Get Access Now

Interested in Group Sales? Learn more

Gastroenterology

RSS  

Articles

  • Vitamin D May Lower the Risk of Dementia

    You saw the title and probably said to yourself "Really? Another use for the star vitamin, vitamin D?" Indeed; it's true.
  • Yoga for Weight Loss

    Weight loss and weight maintenance are often difficult to achieve. Although exercise is recommended as one of the mainstays of treatment, many overweight people have difficulty finding a feasible and enjoyable form of exercise.
  • Clinical Briefs by Louis Kuritzky, MD

    In the general population, there is a linear and reversible relationship between salt intake and blood pressure (BP): more salt in begets higher BP, and salt restriction lowers BP.
  • Roflumilast Tablets (Daliresp®)

    An oral selective phosphodiesterase 4 (pde4) inhibi-tor has been approved for the treatment of patients with chronic obstructive pulmonary disease (COPD). Roflumilast is the first drug of this type to be approved for this indication. It is marketed by Forest Pharmaceuticals as Daliresp.
  • Stopping Aspirin May Increase Stroke Risk

    The health improvement network UK primary care database was queried for all patients aged 50-84 who were prescribed low-dose aspirin (75-300 mg/day) for the secondary prevention of cardiovascular disease in 2000-2007.
  • STD Management — What's New?

    The 2006 Centers for Disease Control and Prevention (CDC) sexually transmitted disease (STD) guidelines have been updated.
  • You're Overweight — There, I've Said It

    People who are told by their physicians that they are overweight or obese are more likely to identify themselves as such, more likely to want to lose weight, and more likely to try.
  • ECG Review: A Woman with Heart Problems

    The ECG above was obtained in the office from a 47-year-old woman who said she had "heart problems" that resulted in hospitalization the month before.
  • Clinical Briefs by Louis Kuritzky, MD

    The action to control cardiovascu-lar risk in diabetes (ACCORD) study is really three studies in one, providing information about blood pressure, glucose, and triglyceride treatment in high-risk diabetic patients.
  • Belimumab Injection (Benlysta™)

    The FDA has approved the first new treatment for systemic lupus erythematosus (SLE) since 1955 when hydroxychloroquine and corticosteroids were approved. Belimumab is a recombinant human IgG1l monoclonal antibody specific for soluble human B lymphocyte stimulator protein (BLyS).